Your search returned 10 results.

Sort
Results
1.
ASO Author Reflections: Normothermic Intraperitoneal Chemotherapy Long-Term for Malignant Peritoneal Mesothelioma. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 33909181
Year: 2021
Citation:
  • Annals of Surgical Oncology. 28(12):7118-7119, 2021 11.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH
2.
The many faces of intraperitoneal chemotherapy. [Review] MedStar authors:
  • Sugarbaker, Paul
PMID:
  • 34875459
Year: 2022
Citation:
  • Surgical Oncology. 40:101676, 2022 Mar.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Abdel Mageed H, Sugarbaker P, Van Der Speeten K
3.
After thirty years of experience with early postoperative intraperitoneal 5-fluorouracil now saying goodbye. [Review] MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 35398760
Year: 2022
Citation:
  • Surgical Oncology. 42:101757, 2022 Jun.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH
4.
Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 25329419
Year: 2014
Citation:
  • British Journal of Surgery. 101(13):1758-65, 2014 Dec.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Surgery/General Surgery
Medline publication type:
  • Journal Article
  • Multicenter Study
Form of publication:
  • Journal Article
All authors:
  • Baratti D, Deraco M, Elias D, Glehen O, Kusamura S, Levine EA, Moran BJ, Morris DL, Peritoneal Surface Oncology Group International (PSOGI), Sardi A, Sugarbaker PH
5.
Decision-Making Analysis for Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: A Survey by the Executive Committee of the Peritoneal Surface Oncology Group International (PSOGI). MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 32920557
Year: 2021
Citation:
  • Oncology. 99(1):41-48, 2021.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bijelic L, de Hingh I, Glatzer M, Glehen O, Goere D, Haller L, Li Y, Moran BJ, Morris DL, Piso P, Putora PM, Quadros CA, Rau B, Steffen T, Sugarbaker P, Yonemura Y
6.
Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival. [Review] MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 28189456
Year: 2017
Citation:
  • European Journal of Surgical Oncology. 43(7):1228-1235, 2017 Jul
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Chang D, Sugarbaker PH
7.
Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative Chemotherapy. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 27858561
Year: 2016
Citation:
  • Journal of oncology practice/American Society of Clinical Oncology. 12(10):928-935, 2016 Oct
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Alexander HR Jr, Deraco M, Hesdorffer M, Sugarbaker PH, Turaga KK
8.
High-grade B-cell lymphoma masquerading as peritoneal lymphomatosis. MedStar authors:
  • Kareff, Samuel
  • Yin, Chao
PMID:
  • 31413062
Year: 2019
Citation:
  • BMJ Case Reports. 12(8), 2019 Aug 13.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Internal Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Feigert J, Kareff S, Yin C
9.
Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. MedStar authors:
  • Sugarbaker, Paul H
  • Yan, Tristan D
PMID:
  • 22614976
Year: 2012
Citation:
  • Journal of Clinical Oncology. 30(20):2449-56, 2012 Jul 10.
Institution:
  • MedStar Washington Hospital Center
  • Washington Cancer Institute
Department:
  • Surgery/General Surgery
Medline publication type:
  • Journal Article
  • Multicenter Study
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Baratti D, Barrios P, Ceelen WP, Chua TC, de Hingh IH, Deraco M, Elias D, Gilly FN, Glehen O, Gomez Portilla A, Gonzalez-Moreno S, Levine EA, Liauw W, Moran BJ, Morris DL, Pelz JO, Piso P, Sardi A, Sugarbaker PH, Van Der Speeten K, Yan TD
10.
Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin. [Review] MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 33004272
Year: 2021
Citation:
  • European Journal of Surgical Oncology. 47(4):738-742, 2021 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Evans S, Nagourney AJ, Nagourney RA, Sugarbaker PH, Tran PH
Pages

Powered by Koha